Last update 25 Jul 2025

Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)

Overview

Basic Info

Drug Type
Interferons, Biosimilar
Synonyms
Infibeta
Target
IFNAR
Action
agonists, modulators
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators
Therapeutic Areas
Immune System DiseasesNervous System DiseasesOther Diseases
Active Indication
Multiple Sclerosis
Inactive Indication-
Originator Organization
International Biotech Center Generium
Active Organization
International Biotech Center Generium
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Kazakhstan (01 Jan 2011),
Multiple Sclerosis
Regulation-
Login to view timeline

Structure/Sequence

Related

100 Clinical Results associated with Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)
Login to view more data
100 Translational Medicine associated with Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)
Login to view more data
100 Patents (Medical) associated with Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)
Login to view more data
7
Literatures (Medical) associated with Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)
01 Jan 2022Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study
01 Jan 2018Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
The results of an open comparative retrospective trial of the course of multiple sclerosis during treatment with infibeta and other interferon-beta bioanalogues and glatiramer acetate
01 Jan 2016Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
The results of an open prospective study of β-interferon biosimilars (an Yaroslavl’ cohort)
100 Deals associated with Interferon beta-1b biosimilar (International Biotech Center Generium, LLC)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L03AB08
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Multiple Sclerosis
Kazakhstan
International Biotech Center Generium
01 Jan 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free